Y. Ohe

PL02.08 Registrational Results of LIBRETTO-001: A Phase 1/2 Trial of LOXO-292 in Patients with RET Fusion-Positive Lung Cancers

Alexander Drilon, Geoffrey R. Oxnard, Lori J. Wirth et al. · Journal of Thoracic Oncology · 2019 · 81 citations · Full text

Medicine, Oncology, Cancer Genetics +10

Effect of Platinum Combined with Irinotecan or Paclitaxel against Large Cell Neuroendocrine Carcinoma of the Lung

Yutaka Fujiwara, Ikuo Sekine, K. Tsuta et al. · Japanese Journal of Clinical Oncology · 2007 · 41 citations · Full text

Medicine, Oncology, Pharmacology +16

Lung Cancer Working Group Report

N Saijo, M. Fukuoka, Sumitra Thongprasert et al. · Japanese Journal of Clinical Oncology · 2010 · 18 citations · Full text

Medicine, Oncology, Pharmacology +13

Comparative study of the antitumor effect of two types of murine recombinant interferons, (?) and (?), against B16-F10 melanoma

Masanori Sakurai, Masaaki Iigo, Tomohide Tamura et al. · Cancer Immunology Immunotherapy · 1988 · 15 citations · Full text

Life Sciences, Immunology, Oncology +12

Efficacy of immune checkpoint inhibitors plus platinum-based chemotherapy as 1st line treatment for patients with non-small cell lung cancer harboring HER2 mutations: Results from LC-SCRUM-Asia

Yuki Kato, Hibiki Udagawa, Shingo Matsumoto et al. · Lung Cancer · 2024 · 15 citations

Medicine, Oncology, Pharmacotherapy +17